EUVIMEDEUVIMED entdecken
Crossref

XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility

Liqing Huang iD, Weiwei Wang, Zhimin Zhu iD, Qianhui Li, Minjun Li, Huan Zhou, Qin Xu iD, Qisheng Wang, Feng Yu iD

Acta Crystallographica Section D Structural Biology · 01.09.2025 · 81 (9) · 482-491

DOI: 10.1107/s2059798325006801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Crystallographica Section D Structural Biology, online erschienen am 11.08.2025. Verfasst von Liqing Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, People's Republic of China. Hauptthemen laut MEDLINE: Synchrotrons, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fragment-based lead discovery (FBLD) is an efficient and effective method for identifying novel chemical scaffolds that have advantages in drug development. X-ray crystallography has an inherent advantage in recognizing low-affinity fragments and integrates fragment identification with complex structure determination, making it an increasingly important tool for screening fragment compounds. Here, we introduce a crystallographic fragment-screening platform developed by the biological macromolecular crystallography group at Shanghai Synchrotron Radiation Facility, named the XFBLD-Platform. This platform promotes fragment-based lead discovery through a comprehensive workflow that includes high-throughput complex crystal preparation, crystal harvesting, diffraction data collection and analysis, and fragment-affinity estimation. It integrates advanced hardware, high-performance beamline facilities and specialized experimental design and data-management software. The platform provides a rapid and practical approach for structure-based drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynchrotronsDrug DiscoveryCrystallography, X-RayChinaSoftware

Stichwörter der Autor:innen

fragment screeningfragment-based lead discoveryprotein crystallographysynchrotron-radiation facilities

Autor:innen und Institutionen

  • Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, People's Republic of China.
  • Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201204, People's Republic of China.

ORCID-Profile: Liqing Huang, Zhimin Zhu, Qin Xu, Feng Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, L., Wang, W., Zhu, Z., Li, Q., Li, M., Zhou, H., Xu, Q., Wang, Q., & Yu, F. (2025). XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility. Acta Crystallographica Section D Structural Biology, 81(9), 482-491. https://doi.org/10.1107/s2059798325006801

Vancouver

Huang L, Wang W, Zhu Z, Li Q, Li M, Zhou H, et al. XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility. Acta Crystallographica Section D Structural Biology. 2025;81(9):482-491. doi:10.1107/s2059798325006801

BibTeX
@article{Huang2025,
  author = {Huang, Liqing and Wang, Weiwei and Zhu, Zhimin and Li, Qianhui and Li, Minjun and Zhou, Huan and Xu, Qin and Wang, Qisheng and Yu, Feng},
  title = {XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility},
  journal = {Acta Crystallographica Section D Structural Biology},
  year = {2025},
  volume = {81},
  number = {9},
  pages = {482--491},
  doi = {10.1107/s2059798325006801}
}
Kostenlos starten →